NeuroBo Pharmaceuticals Inc (NRBO)
2.35
-0.05
(-2.08%)
USD |
NASDAQ |
Nov 21, 16:00
NeuroBo Pharmaceuticals Beta (5Y)
Beta (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Beta (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | -- |
| September 30, 2024 | -- |
| August 31, 2024 | -- |
| July 31, 2024 | -- |
| June 30, 2024 | -- |
| May 31, 2024 | -- |
| April 30, 2024 | -- |
| March 31, 2024 | -- |
| February 29, 2024 | -- |
| January 31, 2024 | -- |
| December 31, 2023 | -- |
| November 30, 2023 | -- |
| October 31, 2023 | -- |
| September 30, 2023 | -- |
| August 31, 2023 | -- |
| July 31, 2023 | -- |
| June 30, 2023 | -- |
| May 31, 2023 | -- |
| April 30, 2023 | -- |
| March 31, 2023 | -- |
| Date | Value |
|---|---|
| February 28, 2023 | -- |
| January 31, 2023 | -- |
| December 31, 2022 | -- |
| November 30, 2022 | -- |
| October 31, 2022 | -- |
| September 30, 2022 | -- |
| August 31, 2022 | -- |
| July 31, 2022 | -- |
| June 30, 2022 | -- |
| May 31, 2022 | -- |
| April 30, 2022 | -- |
| March 31, 2022 | -- |
| February 28, 2022 | -- |
| January 31, 2022 | -- |
| December 31, 2021 | -- |
| November 30, 2021 | -- |
| October 31, 2021 | -- |
| September 30, 2021 | -- |
| August 31, 2021 | -- |
Beta Definition
Beta is a risk metric that measures the risk associated with a security in comparison to the risk associated with the market overall. A beta of 1 would signify that the beta is neutral with the market. A common use of beta is within the Capital Asset Pricing Model (CAPM), to find a security's expected return.